Head-to-head comparison
CoreAge Rx vs StackMD
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
One price at every dose, both molecules, all 50 states. The $99 and $149 figures are 12-month plans paid up front, not a monthly bill.
$99/mo (12-month prepay) sema · $149/mo (12-month prepay) tirz · Verified August 2026
Marked down on: The advertised $99/$149 per month is a 12-month plan paid in full ($1,188 / $1,788 up front); no month-to-month price is published
Desk Score
StackMD is a New York telehealth platform (Medical 360 HC PLLC) selling compounded semaglutide and tirzepatide, both formulated with B12 and glycine, alongside NAD+, sermorelin and other longevity peptides.
$199 (see conditions) sema · $299 (see conditions) tirz · Verified August 2026
Marked down on: ⛔ Four different semaglutide figures across two pages in August 2026 — $125 and $125/month on the home page, $199 and $99/month on the product page — under a header that promises 'Transparent Pricing'
CoreAge Rx takes this head-to-head with the higher Desk Score, 94/100 (A) against 69/100 (C) for StackMD. StackMD still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
CoreAge Rx
94/100
A
StackMD
69/100
C
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | CoreAge Rx | StackMD |
|---|---|---|
| Semaglutide | $99/mo12-month prepay$99/mo only as a 12-month plan paid in full ($1,188 in one charge); the lander says "starting at, based on a 12-month plan paid in full"; no month-to-month price is published; same price at every dose; compounded injectable | $199see conditions$199 on the product page (the home card says $125 and the same page's own block says $99/mo; no billing cycle stated at checkout, compounded) |
| Tirzepatide | $149/mo12-month prepay$149/mo only as a 12-month plan paid in full ($1,788 in one charge); no month-to-month price is published; same price at every dose; compounded injectable | $299see conditions$299 on the product page (the home card says $199; no billing cycle stated at checkout, compounded) |
| Coverage | All 50 states | All 50 states |
| Brand-name | Compounded only | Compounded only |
| Oral option | Injectable only | Injectable only |
| Best for | Anyone who can prepay a year and wants one dose-independent price with full nationwide reach. | A patient who has already chosen StackMD for another reason and is prepared to discover the real charge at checkout — not for anyone shopping on price. |
| Desk Score | 94/100A | 69/100C |
The verdict
Desk pick — CoreAge RxCoreAge Rx takes this head-to-head with the higher Desk Score, 94/100 (A) against 69/100 (C) for StackMD. StackMD still holds its ground where its strengths line up with yours.
Choose CoreAge Rx if…
Anyone who can prepay a year and wants one dose-independent price with full nationwide reach.
$99/mo (12-month prepay) sema · $149/mo (12-month prepay) tirz · All 50 states
Choose StackMD if…
A patient who has already chosen StackMD for another reason and is prepared to discover the real charge at checkout — not for anyone shopping on price.
$199 (see conditions) sema · $299 (see conditions) tirz · All 50 states
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we write about a provider reads the same either way. Read full breakdowns: CoreAge Rx · StackMD.
More head-to-heads
- CoreAge Rx vs Strut Health
- HealthRX vs StackMD
- CoreAge Rx vs Ondra Health
- RestorLife Med vs StackMD
- CoreAge Rx vs Sesame Care
- Renlo Health vs StackMD
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.